To test the association of the AP-2alpha gene expression signature with additional human cancers, we queried its association with therapeutic inhibitors in the broader panel of 9 cancer cell lines and 3,096 therapeutic inhibitors in LINCS. This evidence concerns the gene SERPINF2 and cancer.